Athersys Inc
Biotechnology
Healthcare
ATHX
11.86 M shares
NASDAQ US
traded
27 Mar 2023
listed
yes
open
1.34
52 week high
3.10
high
1.41
52 week low
1.32
low
1.26
growth
-47.04 %
previous Close
1.35
P/E ratio
-1
market cap
26.33 M
div yield
0
usd
Sep 2022
qoq
revenue
65.00 K
-97.19 %
net incoming
-13.67 M
0.00 %
eps
-1.15 %
-1.00 %
eps surprise
41.33 %
net profit margin
-21029.23 %
-21029.00 %
operating incoming
-16.71 M
31.10 %
net change in cash
404 K
104.80 %
cash on hand
13.78 M
3.02 %
cost of revenue
0.00 %
top top